Mario Lecha

Summary

Country: Spain

Publications

  1. ncbi Erythropoietic protoporphyria
    M Lecha
    , University of Barcelona, Spain
    Photodermatol Photoimmunol Photomed 19:142-6. 2003
  2. ncbi Erythropoietic protoporphyria
    Mario Lecha
    Department of Dermatology, Hospital Clinic, University of Barcelona, Barcelona, Spain
    Orphanet J Rare Dis 4:19. 2009
  3. ncbi Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain
    M Lecha
    Hospital Clinic Barcelona, Spain
    Br J Dermatol 145:21-6. 2001
  4. ncbi Diagnosis and treatment of the hepatic porphyrias
    M Lecha
    Department of Dermatology, Hospital Clinic, University of Barcelona, Barcelona, Spain
    Dermatol Ther 16:65-72. 2003
  5. ncbi Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience
    M Lecha
    Hospital Clinic de Barcelona, Servicio de Dermatologia, Villaroel 170, 08036 Barcelona, Spain
    J Eur Acad Dermatol Venereol 19:414-7. 2005
  6. ncbi Clinical, biochemical, and genetic study of 11 patients with erythropoietic protoporphyria including one with homozygous disease
    Carmen Herrero
    Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS Institut d Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
    Arch Dermatol 143:1125-9. 2007
  7. ncbi Treatment options--development of consensus guidelines
    M Lecha
    Servicio de Dermatologia, Hospital Clinic i Provincial de Barcelona, Villarroel, Barcelona, Spain
    J Eur Acad Dermatol Venereol 19:25-33. 2005
  8. ncbi Study of the genotype-phenotype relationship in four cases of congenital erythropoietic porphyria
    Jordi To-Figueras
    Biochemistry and Molecular Genetics Unit, Dermatology Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Villarroel 170, Barcelona 08036, Spain
    Blood Cells Mol Dis 38:242-6. 2007
  9. ncbi Genetic studies in variegate porphyria in Spain. Identification of gene mutations and family study for carrier detection
    M Lecha
    Department of Dermatology, Facultat de Medicina, Universitat de Barcelona, Spain
    J Eur Acad Dermatol Venereol 20:974-9. 2006
  10. ncbi Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation
    J To-Figueras
    Biochemistry and Molecular Genetics Unit, Dermatology Unit, Hospital Clinic i Provincial, IDIBAPS, University of Barcelona, Barcelona, Spain
    J Inherit Metab Dis 29:580-5. 2006

Collaborators

Detail Information

Publications20

  1. ncbi Erythropoietic protoporphyria
    M Lecha
    , University of Barcelona, Spain
    Photodermatol Photoimmunol Photomed 19:142-6. 2003
  2. ncbi Erythropoietic protoporphyria
    Mario Lecha
    Department of Dermatology, Hospital Clinic, University of Barcelona, Barcelona, Spain
    Orphanet J Rare Dis 4:19. 2009
    ..EPP is a lifelong disorder whose prognosis depends on the evolution of the hepatic disease. However, photosensitivity may have a significant impact on quality of life of EPP patients...
  3. ncbi Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain
    M Lecha
    Hospital Clinic Barcelona, Spain
    Br J Dermatol 145:21-6. 2001
    ..In an open, randomized, clinical study of toenail onychomycosis with matrix area involvement, two alternative regimens of topical amorolfine/oral itraconazole therapy were compared with itraconazole monotherapy...
  4. ncbi Diagnosis and treatment of the hepatic porphyrias
    M Lecha
    Department of Dermatology, Hospital Clinic, University of Barcelona, Barcelona, Spain
    Dermatol Ther 16:65-72. 2003
    ..Unfortunately no curative treatment is available for any of the porphyrias. However, symptomatic treatments are available and are discussed in this article...
  5. ncbi Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience
    M Lecha
    Hospital Clinic de Barcelona, Servicio de Dermatologia, Villaroel 170, 08036 Barcelona, Spain
    J Eur Acad Dermatol Venereol 19:414-7. 2005
    ..A group of vitamin D derivatives has revealed to be an efficient treatment for psoriasis. Different types of studies have been designed to confirm the efficacy of its use without relevant side-effects...
  6. ncbi Clinical, biochemical, and genetic study of 11 patients with erythropoietic protoporphyria including one with homozygous disease
    Carmen Herrero
    Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS Institut d Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
    Arch Dermatol 143:1125-9. 2007
    ..To study the mutations in the ferrochelatase gene (FECH) and the phenotypic expression of erythropoietic protoporphyria (EPP) in a group of Spanish patients...
  7. ncbi Treatment options--development of consensus guidelines
    M Lecha
    Servicio de Dermatologia, Hospital Clinic i Provincial de Barcelona, Villarroel, Barcelona, Spain
    J Eur Acad Dermatol Venereol 19:25-33. 2005
    ..g. an illustrated booklet or CD-ROM presenting each type of onychomycosis and criteria to be considered before selecting treatment regimen) would be valuable supports for the successful treatment of onychomycoses...
  8. ncbi Study of the genotype-phenotype relationship in four cases of congenital erythropoietic porphyria
    Jordi To-Figueras
    Biochemistry and Molecular Genetics Unit, Dermatology Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Villarroel 170, Barcelona 08036, Spain
    Blood Cells Mol Dis 38:242-6. 2007
    ....
  9. ncbi Genetic studies in variegate porphyria in Spain. Identification of gene mutations and family study for carrier detection
    M Lecha
    Department of Dermatology, Facultat de Medicina, Universitat de Barcelona, Spain
    J Eur Acad Dermatol Venereol 20:974-9. 2006
    ..Second, study of carrier status detection in the families, including a four-generation Balearic family. Third, evaluation of the results of carrier detection screening methods...
  10. ncbi Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation
    J To-Figueras
    Biochemistry and Molecular Genetics Unit, Dermatology Unit, Hospital Clinic i Provincial, IDIBAPS, University of Barcelona, Barcelona, Spain
    J Inherit Metab Dis 29:580-5. 2006
    ..These results reinforce the hypothesis that the R173W mutation may have a high biochemical and clinical penetrance among AIP patients...
  11. ncbi Photosensitivity induced by paroxetine
    J Vilaplana
    Department of Dermatology, Hospital Clinic, Barcelona, Spain
    Contact Dermatitis 47:118-9. 2002
  12. ncbi Urinary porphyrin excretion in a human population highly exposed to hexachlorobenzene
    C Herrero
    Department of Dermatology, August Pi Sunyer Biomedical Research Institute, Hospital Clinic, Faculty of Medicine, University of Barcelona, Spain
    Arch Dermatol 135:400-4. 1999
    ..No information is available on the HCB threshold exposure level to induce porphyria cutanea tarda...
  13. ncbi Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial
    J P Ortonne
    Service de Dermatologie, Hopital de l Archet, Nice, France
    Dermatology 209:308-13. 2004
    ..A two-compound product containing calcipotriol 50 microg/g and betamethasone dipropionate 0.5 mg/g (Daivobet, Dovobet) has been demonstrated to be an effective, once daily, treatment for psoriasis vulgaris...
  14. ncbi [Registry of home-based enteral nutrition in Spain for the year 2006 (NADYA-SENPE Group)]
    C Cuerda
    Unidad de Nutrición, Hospital General Universitario Gregorio Maranon, Madrid, Espana
    Nutr Hosp 23:95-9. 2008
    ..To communicate the results obtained from the registry of Home-Based Enteral Nutrition (HBEN) of the NADYA-SENPE group for the year 2006...
  15. ncbi [National registry of Home Enteral Nutrition in 2003]
    M Planas
    Unidad de Nutrición y Dietética, Hospital Universitario Vall d Hebron, Barcelona, Espana
    Nutr Hosp 21:71-4. 2006
    ..To communicate the information available by the NADYA-SENPE Working Group from patients on Home Enteral Nutrition (HEN) in our country during the year 2003...
  16. ncbi Epidemiology and clinical classification of onychomycosis
    I Effendy
    Hautklinik, Klinikum Rosenhöhe, Städtische Kliniken Bielefeld, An der Rosenhöhe 27, Bielefeld, Germany
    J Eur Acad Dermatol Venereol 19:8-12. 2005
    ..To review recent data - what is new in the epidemiology of onychomycoses? To identify the most relevant diagnostic criteria for effective therapy...
  17. ncbi [The year 2002 national registry on home-based enteral nutrition]
    M Planas
    , , km. 5, 400 28041, Madrid
    Nutr Hosp 20:254-8. 2005
    ..The high prevalence of cancer patients could be the main cause of oral access for enteral nutrition. Change of enteral tube was the more frequent complication observed during this treatment...
  18. ncbi [The year 2002 national register on home-based parenteral nutrition]
    J M Moreno
    Unidad de Nutrición Clínica, Hospital 12 de Octubre Ctra de Andalucía, km 5, 400 28041, Madrid
    Nutr Hosp 20:249-53. 2005
    ..To report on the results of the Registry on Home-based Parenteral Nutrition (HPN) of the NADYA-SENPE working group, corresponding to the year 2002...
  19. ncbi Description of a new mutation in hepatoerythropoietic porphyria and prenatal exclusion of a homozygous fetus
    Cecile Ged
    Laboratoire de Pathologie Moléculaire et Thérapie Génique, Universite Victor Segalen Bordeaux 2, 146, rue Leo Saignat, 33076 Bordeaux Cedex, France
    Arch Dermatol 138:957-60. 2002
    ....
  20. ncbi Mutations in the ferrochelatase gene of four Spanish patients with erythropoietic protoporphyria
    L Gouya
    Center Francais des Porphyries, INSERM, Hopital Louis Mourier, Colombes, France
    J Invest Dermatol 111:406-9. 1998
    ....